For Stage 1 ATTR amyloidosis, which is characterized by normal levels of both NT-proBNP and eGFR biomarkers, patients have an average life expectancy of 5.8 years after diagnosis. This represents the best prognosis among the different stages of ATTR amyloidosis. Wild-type ATTR amyloidosis generally has a positive outlook Show Full Answer
For Stage 1 ATTR amyloidosis, which is characterized by normal levels of both NT-proBNP and eGFR biomarkers, patients have an average life expectancy of 5.8 years after diagnosis. This represents the best prognosis among the different stages of ATTR amyloidosis. Wild-type ATTR amyloidosis generally has a positive outlook, with studies showing an 85% survival rate at the one-year follow-up mark. The disease typically progresses more slowly than other forms of amyloidosis, as it develops gradually over time as amyloid deposits form. However, the presence of severe heart complications can impact the overall prognosis.
AI-generated responses are not a substitute for medical advice. These services are not intended to
diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.
Stages of Amyloidosis
Can Amyloidosis Be Cured?
April 12, 2025